![]() We’re excited to continue that growth trajectory, recognizing the value created in our trusted brands, our considerable operational efficiencies and an innovative new product pipeline. Scott Cramer, President and CEO, DDC commented: “With GHO’s support, we are proud of the consistent and consecutive year on year growth DDC has achieved. DDC will significantly benefit from the tremendous resources, expertise and expanded global reach of Eurofins – leveraging their scientific bench to bring new products to our customers. This transaction will further the market-leading position of Eurofins by expanding its reach into the consumer genetics and health and wellness markets. A series of four add-on acquisitions saw DDC further penetrate European markets as well as diversify its product offering into medically led consumer testing, home healthcare and fertility. Significant investment was made in the operating infrastructure of the business to build an organization established in delivering consistent year on year growth. ![]() In partnership with GHO, DDC experienced strong growth both organically and through strategic acquisitions. The Company, with approximately 240 employees, will continue to operate from its existing Fairfield, OH facility. In response to the global pandemic, DDC demonstrated its strength and resilience through new product launches and partnerships, with revenue increasing in excess of $55M in 2021. The Company is among the nation’s top laboratories and is well known for leading consumer brands including SpermCheck ®, HomePaternity ® and Peekaboo TM Early Gender Detection. This transaction follows a successful partnership between DDC and GHO Capital (“GHO”), the European specialist investor in global healthcare.ĭDC is a multichannel, global leader in consumer-focused DNA testing, offering best in class DNA lab and testing services across a range of sectors including family relationships, immigration, gender, fertility and health and wellness. FAIRFIELD, Ohio-( BUSINESS WIRE)-DNA Diagnostics Center (“DDC”), announced today the definitive agreement to be acquired by Eurofins, a publicly traded, global laboratory testing business.
0 Comments
Leave a Reply. |